Cidofovir

This classification denotes an antiviral agent with the molecular formula C8H14N3O6P.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, JIL713Q00N chemically known as phosphonic acid, ((2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, dihydrate, (s)- but generally known as cidofovir, which bears US NIH Compound Identifier 60613. European Medicines Agency schedules Cidofovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06257MIG. The term CIDOFOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35. ). Most nations schedule cidofovir under HS 29335995 and SITC 51576. As of Q4 2014, CIDOFOVIR remains the US FDA Preferred Term for this commodity. Cidofovir bears US NLM identifiers UMLS ID C0286079 and NCI Concept Code C1600. SMILES: P(=O)(O)(O)COC(CN1CCC(NC1=O)N)CO.